載入中
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
前收盤價
US$64.11
+US$0.98 · +1.55%
盤中時間採用ET。市場資料可能有所延遲。
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
日內區間
目前US$64.11
52週區間
目前US$64.11
盤中時間採用ET。市場資料可能有所延遲。
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
日內區間
目前US$64.11
52週區間
目前US$64.11
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 104.01億 USD | 99.11億 USD | 94.55億 USD | 87.17億 USD | 82.91億 USD |
| 銷貨成本 | 46.56億 USD | 43.99億 USD | 42.08億 USD | 39.69億 USD | 36.39億 USD |
| 毛利 | 57.45億 USD | 55.12億 USD | 52.47億 USD | 47.48億 USD | 46.52億 USD |
| 研究與開發 | 9.9億 USD | 8.76億 USD | 8.59億 USD | 7.02億 USD | 8.42億 USD |
| 銷售、一般及管理費用 | 34.49億 USD | 32.5億 USD | 32.09億 USD | 30.68億 USD | 30.76億 USD |
| 營業費用 | 43.85億 USD | 40.99億 USD | 42.08億 USD | 40.76億 USD | 40.72億 USD |
| 利息收入 | 7400萬 USD | 8145.4萬 USD | 3400萬 USD | 1652.49萬 USD | 300.64萬 USD |
| 利息支出 | 2.04億 USD | 1.86億 USD | 1.89億 USD | 1.38億 USD | 1.2億 USD |
| 折舊和攤銷 | 13.35億 USD | 12.28億 USD | 12.21億 USD | 11.23億 USD | 12.19億 USD |
| 營業利益 | 13.6億 USD | 14.13億 USD | 10.39億 USD | 6.72億 USD | 5.8億 USD |
| 淨利 | 9.8億 USD | 10.18億 USD | 9.74億 USD | 3.35億 USD | 3.76億 USD |
公司資料更新於 2026年10月11日。
報告持有此股票曝險的交易所交易基金。
Kovitz Core Equity ETFEQTY3944.72萬3.06%14.27億 USD0.99%US$29.445+0.42%
Dimensional - International Value ETFDFIV3099.27萬0.15%213.87億 USD0.27%US$55.42+0.25%
Dimensional - International Core Equity Market ETFDFAI1707.9萬0.10%177.82億 USD0.18%US$41.34+0.66%
Dimensional - International Core Equity 2 ETFDFIC1414.55萬0.10%150.17億 USD0.22%US$37.53+0.64%
Dimensional World ex U.S. Core Equity 2 ETFDFAX737.78萬0.06%123.36億 USD0.28%US$37.08+0.76%
Running Oak Efficient Growth ETFRUNN674.68萬1.73%3.89億 USD0.58%US$33.3034+0.44%
John Hancock Investments - Multifactor Developed International ETFJHMD299.09萬0.31%9.65億 USD0.39%US$44.09+0.52%
Invesco RAFI Developed Markets ex-U.S. ETFPXF288.56萬0.10%29.06億 USD0.43%US$75.89+0.37%Kovitz Core Equity ETFEQTYDimensional - International Value ETFDFIVDimensional - International Core Equity Market ETFDFAIDimensional - International Core Equity 2 ETFDFICDimensional World ex U.S. Core Equity 2 ETFDFAXRunning Oak Efficient Growth ETFRUNNJohn Hancock Investments - Multifactor Developed International ETFJHMDInvesco RAFI Developed Markets ex-U.S. ETFPXFAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
